Toward specific cardiac I(K1) modulators for in vivo application: old drugs point the way.
about
Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP2 interference.Novel molecular targets for atrial fibrillation therapy.Finding inward rectifier channel inhibitors: why and how?Inhibiting the clathrin-mediated endocytosis pathway rescues K(IR)2.1 downregulation by pentamidine.Efficient and specific cardiac IK₁ inhibition by a new pentamidine analogue.Efficacy of pentamidine analogue 6 in dogs with chronic atrial fibrillation
P2860
Toward specific cardiac I(K1) modulators for in vivo application: old drugs point the way.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Toward specific cardiac I
@nl
Toward specific cardiac I(K1) ...... tion: old drugs point the way.
@en
type
label
Toward specific cardiac I
@nl
Toward specific cardiac I(K1) ...... tion: old drugs point the way.
@en
prefLabel
Toward specific cardiac I
@nl
Toward specific cardiac I(K1) ...... tion: old drugs point the way.
@en
P1433
P1476
Toward specific cardiac I(K1) modulators for in vivo application: old drugs point the way
@en
P2093
José A Sánchez-Chapula
P304
P356
10.1016/J.HRTHM.2011.01.038
P577
2011-02-02T00:00:00Z